Repros Therapeutics Inc. (RPRX) Announces Pricing of Public Offering of Common Stock  
6/20/2013 8:51:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas, June 19, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (Nasdaq:RPRX) today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of $19.00 per share, before underwriting discounts and other offering expenses. The gross proceeds from the sale of the shares, before underwriting discounts and other offering expenses, are expected to be $71.25 million. The offering is expected to close on June 25, 2013, subject to customary closing conditions. Repros Therapeutics has also granted the underwriters a 30-day option to purchase up to 562,500 additional shares of common stock. All of the shares in the offering are to be sold by Repros Therapeutics Inc.

Help employers find you! Check out all the jobs and post your resume.